Pharmatech Hires Richard Aleman to Lead Regulatory Compliance

HAYWARD, Calif.--(BUSINESS WIRE)--Pharmatech Associates today announced the appointment of international regulatory expert Richard Aleman as vice president of Regulatory Compliance. Aleman, a 28-year veteran of the U.S. Food and Drug Administration (FDA), brings supervisory experience in the regulatory and enforcement arenas, with knowledge of the compliance issues confronting the drug, biologics, medical devices and dietary supplement industries.

"Richard is an outstanding addition to our expert executive team in terms of FDA and international requirements, and our customers will benefit greatly from his wealth of insight."
"Pharmatech's regulatory approach of achieving compliance through science aligns with the requirements of global regulatory authorities for quality and product predictability," said Bikash Chatterjee, Pharmatech's president and CSO. "Richard is an outstanding addition to our expert executive team in terms of FDA and international requirements, and our customers will benefit greatly from his wealth of insight."

"What sets Pharmatech apart is this group's ability to partner with its customers, based on their practical understanding of the product development lifecycle in every phase," said Richard Aleman. "I look forward to helping Pharmatech become the undisputed leader in our field of endeavor."

While at the FDA, Aleman worked in the field and at headquarters organizations, focusing on biopharmaceuticals, drugs, and medical devices. His international experience includes assignments with the Food and Agricultural Organization of the United Nations (FAO), US AID, the World Health Organization (WHO), and the United States Pharmacopeia (USP), where he was lead auditor, as well as representing the FDA at conferences in Latin America, North America, and the Philippines. Transitioning from government service to the regulated industry, Aleman served as Director of Compliance for small to mid-size pharmaceutical companies, dealing with quality assurance, quality control and regulatory affairs.

About Pharmatech Associates

Staffed by industry experts, Pharmatech Associates (founded in 1995) provides consulting and services to the regulated life science industry. Pharmatech's services cover four spheres of technical expertise that are necessary throughout the complete product development lifecycle: Product and Process Development, Compliance, Regulatory, and Validation. Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in Asia, Europe and North America from its headquarters in the San Francisco Bay Area. www.pharmatechassociates.com

Contacts

SIPR for Pharmatech
Judy Curtis, +1 650-274-1509
[email protected]

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.